SEC Filing Summary: eXegenics Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by eXegenics Inc., a Delaware corporation, on March 19, 2003. The report serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The filing primarily addresses Item 9 (Regulation FD Disclosure) and includes a certification under Section 906 of the Sarbanes-Oxley Act of 2002 regarding the company's Annual Report on Form 10-K for the year ended December 31, 2002.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document is a certification of compliance rather than a financial statement. It confirms that the previously filed Form 10-K for the fiscal year ended December 31, 2002, fairly presents the company's financial condition and results of operations.
Material Changes
No material changes to financial performance or operations are disclosed in this specific filing. The report focuses on the legal certification of the accuracy of the prior year's annual report.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future outlook, or specific discussion of risks and contingencies. The primary content is the attestation by the Principal Executive Officer and Chief Financial Officer that the Form 10-K complies with the Securities Exchange Act of 1934.
Key Facts for Investor Verification
- Verify the contents of the Form 10-K for the year ended December 31, 2002, as this 8-K certifies its accuracy but does not repeat the data.
- Confirm the identities of the certifying officers: Ronald L. Goode (President and CEO) and David E. Riggs (CFO).
- Note that the registrant's name in the filing is eXegenics Inc., distinct from the metadata field "OPKO HEALTH, INC."
- Check for any subsequent filings that may contain the actual financial figures referenced in the certified 10-K.